Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$15.31 - $26.52 $1.38 Million - $2.39 Million
-90,000 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$5.24 - $23.4 $471,600 - $2.11 Million
90,000 New
90,000 $2.11 Million
Q4 2019

Feb 14, 2020

SELL
$1.45 - $6.73 $599,611 - $2.78 Million
-413,525 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$1.54 - $4.2 $3.16 Million - $8.61 Million
-2,050,890 Reduced 83.22%
413,525 $653,000
Q2 2019

Aug 14, 2019

SELL
$3.84 - $6.4 $2.89 Million - $4.81 Million
-751,587 Reduced 23.37%
2,464,415 $9.98 Million
Q1 2019

May 15, 2019

BUY
$3.51 - $7.3 $4.17 Million - $8.68 Million
1,188,497 Added 58.62%
3,216,002 $16.9 Million
Q4 2018

Feb 14, 2019

BUY
$3.45 - $9.72 $645,743 - $1.82 Million
187,172 Added 10.17%
2,027,505 $8.27 Million
Q3 2018

Nov 14, 2018

BUY
$10.0 - $19.02 $5.89 Million - $11.2 Million
589,356 Added 47.11%
1,840,333 $18.4 Million
Q2 2018

Aug 14, 2018

BUY
$14.2 - $22.68 $4.52 Million - $7.23 Million
318,581 Added 34.17%
1,250,977 $22.3 Million
Q1 2018

May 15, 2018

BUY
$13.56 - $18.48 $442,367 - $602,873
32,623 Added 3.63%
932,396 $14.7 Million
Q4 2017

Feb 14, 2018

BUY
$14.95 - $19.9 $6.31 Million - $8.4 Million
422,062 Added 88.35%
899,773 $14.8 Million
Q3 2017

Nov 14, 2017

BUY
$14.8 - $18.06 $7.07 Million - $8.63 Million
477,711
477,711 $8.26 Million

Others Institutions Holding MRSN

About Mersana Therapeutics, Inc.


  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $45.7M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Arrow Mark Colorado Holdings LLC Portfolio

Follow Arrow Mark Colorado Holdings LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.